176 related articles for article (PubMed ID: 17988369)
1. Effects of psychotropics on glycosylated hemoglobin (HbA1c) in a cohort of bipolar patients.
Castilla-Puentes R
Bipolar Disord; 2007 Nov; 9(7):772-8. PubMed ID: 17988369
[TBL] [Abstract][Full Text] [Related]
2. Psychotropic use and risk of stroke among patients with bipolar disorders: 10-year nationwide population based study.
Wu CS; Wu KY; Lo YR; Huang YW; Tsai YT; Li Y; Tsai HJ
J Affect Disord; 2018 Jan; 226():77-84. PubMed ID: 28964996
[TBL] [Abstract][Full Text] [Related]
3. Psychotropic medications for patients with bipolar disorder in the United States: polytherapy and adherence.
Baldessarini R; Henk H; Sklar A; Chang J; Leahy L
Psychiatr Serv; 2008 Oct; 59(10):1175-83. PubMed ID: 18832504
[TBL] [Abstract][Full Text] [Related]
4. Use of mood stabilizers for hospitalized psychotic and bipolar disorder patients.
Ventriglio A; Vincenti A; Centorrino F; Talamo A; Fitzmaurice G; Baldessarini RJ
Int Clin Psychopharmacol; 2011 Mar; 26(2):88-95. PubMed ID: 21030870
[TBL] [Abstract][Full Text] [Related]
5. Treatments for late-life bipolar disorder.
Aziz R; Lorberg B; Tampi RR
Am J Geriatr Pharmacother; 2006 Dec; 4(4):347-64. PubMed ID: 17296540
[TBL] [Abstract][Full Text] [Related]
6. Patterns of psychotropic drug prescription for U.S. patients with diagnoses of bipolar disorders.
Baldessarini RJ; Leahy L; Arcona S; Gause D; Zhang W; Hennen J
Psychiatr Serv; 2007 Jan; 58(1):85-91. PubMed ID: 17215417
[TBL] [Abstract][Full Text] [Related]
7. Diabetes mellitus risk for 102 drugs and drug combinations used in patients with bipolar disorder.
Nestsiarovich A; Kerner B; Mazurie AJ; Cannon DC; Hurwitz NG; Zhu Y; Nelson SJ; Oprea TI; Crisanti AS; Tohen M; Perkins DJ; Lambert CG
Psychoneuroendocrinology; 2020 Feb; 112():104511. PubMed ID: 31744781
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological Treatment Patterns at Study Entry for the First 500 STEP-BD Participants.
Ghaemi SN; Hsu DJ; Thase ME; Wisniewski SR; Nierenberg AA; Miyahara S; Sachs G
Psychiatr Serv; 2006 May; 57(5):660-5. PubMed ID: 16675760
[TBL] [Abstract][Full Text] [Related]
9. Rational polypharmacy in the bipolar affective disorders.
Post RM; Ketter TA; Pazzaglia PJ; Denicoff K; George MS; Callahan A; Leverich G; Frye M
Epilepsy Res Suppl; 1996; 11():153-80. PubMed ID: 9294735
[TBL] [Abstract][Full Text] [Related]
10. Degree of exposure to psychotropic medications and mortality in people with bipolar disorder.
Lin CC; Yeh LL; Pan YJ
Acta Psychiatr Scand; 2023 Feb; 147(2):186-197. PubMed ID: 36217288
[TBL] [Abstract][Full Text] [Related]
11. [Antipsychotics in bipolar disorders].
Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
[TBL] [Abstract][Full Text] [Related]
12. Psychotropic Drugs and Adverse Kidney Effects: A Systematic Review of the Past Decade of Research.
Damba JJ; Bodenstein K; Lavin P; Drury J; Sekhon H; Renoux C; Trinh E; Rej S; Greenway KT
CNS Drugs; 2022 Oct; 36(10):1049-1077. PubMed ID: 36161425
[TBL] [Abstract][Full Text] [Related]
13. Risk of recurrence in women with bipolar disorder during pregnancy: prospective study of mood stabilizer discontinuation.
Viguera AC; Whitfield T; Baldessarini RJ; Newport DJ; Stowe Z; Reminick A; Zurick A; Cohen LS
Am J Psychiatry; 2007 Dec; 164(12):1817-24; quiz 1923. PubMed ID: 18056236
[TBL] [Abstract][Full Text] [Related]
14. Comparative neurocognitive effects of 5 psychotropic anticonvulsants and lithium.
Gualtieri CT; Johnson LG
MedGenMed; 2006 Aug; 8(3):46. PubMed ID: 17406176
[TBL] [Abstract][Full Text] [Related]
15. Current psychotropic medication prescribing patterns in late-life bipolar disorder.
Rej S; Herrmann N; Shulman K; Fischer HD; Fung K; Gruneir A
Int J Geriatr Psychiatry; 2017 Dec; 32(12):1459-1465. PubMed ID: 27911003
[TBL] [Abstract][Full Text] [Related]
16. Psychiatric and physical outcomes of long-term use of lithium in older adults with bipolar disorder and major depressive disorder: A cross-sectional multicenter study.
Morlet E; Costemale-Lacoste JF; Poulet E; McMahon K; Hoertel N; Limosin F;
J Affect Disord; 2019 Dec; 259():210-217. PubMed ID: 31446382
[TBL] [Abstract][Full Text] [Related]
17. Treatment-refractory bipolar disorder: classification to aid in clinical management.
Gajwani P
Expert Opin Pharmacother; 2009 Aug; 10(12):1907-15. PubMed ID: 19606936
[TBL] [Abstract][Full Text] [Related]
18. Real-world Effectiveness of Pharmacologic Treatments for the Prevention of Rehospitalization in a Finnish Nationwide Cohort of Patients With Bipolar Disorder.
Lähteenvuo M; Tanskanen A; Taipale H; Hoti F; Vattulainen P; Vieta E; Tiihonen J
JAMA Psychiatry; 2018 Apr; 75(4):347-355. PubMed ID: 29490359
[TBL] [Abstract][Full Text] [Related]
19. [Somatic side effects of psychopharmaceuticals].
Schmidmeier R
MMW Fortschr Med; 2006 Nov; 148(46):27-9. PubMed ID: 17615784
[TBL] [Abstract][Full Text] [Related]
20. Lithium is associated with decrease in all-cause and suicide mortality in high-risk bipolar patients: A nationwide registry-based prospective cohort study.
Toffol E; Hätönen T; Tanskanen A; Lönnqvist J; Wahlbeck K; Joffe G; Tiihonen J; Haukka J; Partonen T
J Affect Disord; 2015 Sep; 183():159-65. PubMed ID: 26005778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
